Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-29

FDA Approved: LEVETIRACETAM — Supplemental Application (Solco healthcare U.S., LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic levetiracetam formulation developed by Solco Healthcare U.S., LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam (generic) (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)